chrisvoncsefalvay/vaers-outcomes huggingface dataset:
didn't want to eat anything; very dizzy; falling asleep; stomach upset; very achy/Arm hurt more than after first dose; fever a little over 100; chills; tired; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (didn't want to eat anything), DIZZINESS (very dizzy), SOMNOLENCE (falling asleep), ABDOMINAL DISCOMFORT (stomach upset) and PAIN (very achy/Arm hurt more than after first dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 003B21A)) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Egg allergy.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced DECREASED APPETITE (didn't want to eat anything), DIZZINESS (very dizzy), SOMNOLENCE (falling asleep), ABDOMINAL DISCOMFORT (stomach upset), PAIN (very achy/Arm hurt more than after first dose), PYREXIA (fever a little over 100), CHILLS (chills) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (didn't want to eat anything), DIZZINESS (very dizzy), SOMNOLENCE (falling asleep), ABDOMINAL DISCOMFORT (stomach upset), PAIN (very achy/Arm hurt more than after first dose), PYREXIA (fever a little over 100), CHILLS (chills) and FATIGUE (tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, Body temperature: 100 (High) fever a little over 100.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-064687, US-MODERNATX, INC.-MOD-2021-058251 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-064687:dose 1 US-MODERNATX, INC.-MOD-2021-058251:Sister case
On the CDC sheets, Patient checked that he had an  allergic  reaction to the both doses and is allergic to polysorbate that can be found in some vaccine. He also stated that he is severely immunocompromised and received HCT therapies since receiving COVID-19. We should have not given the booster
pt recv vax 3 doses of vax on 22MAYA86 & seroconverted;3mo p/vax pt found to have protective anti-HBs;in 1991 pt anti-HBs positive;MAY95 pt found to be core antibody positive;
Redness, pain, and swelling at site of injection, limiting arm mobility; followed by 36 hours of intermittent fever, chills, ringing in ears, fatigue, and confusion. If these continue to 48 hours, will consult physician.
L armpit swollen; L armpit lymph nodes swollen; Sensation of heaviness left arm; painful scapular area; This is a spontaneous report from a contactable other health professional (patient). A 44-years-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/ Lot number: eh9899), intramuscularly on 22Dec2020 12:30 at single dose on left arm for COVID-19 immunization in hospital. Medical history included ongoing hypertension, allergic to shellfish. Concomitant medication within 2 weeks of vaccination included losartan, hydrochlorothiazide, vitamin C [ASCORBIC ACID], colecalciferol (VITAMIN D), zinc, paracetamol (TYLENOL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced L armpit swollen/ L armpit lymph nodes swollen, sensation of heaviness left arm and painful scapular area from 23Dec2020 15:30. No treatment received for the adverse events. The outcome of events was not recovered. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19. It was not reported as serious.
patients administered Moderna vaccine while temperature excursion assessment was ongoing; patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 Vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.   This case was linked to MOD-2022-501575 (Patient Link).
Patient experienced extreme pain and weakness in lower extremities resulting in hospitalization. Issues were resolved following 3 days in hospital. No treatment was given per son during stay.
feelings of unease developed about 22 hours post vaccine,, abour 2:30 pm,  series of five vomits  took place, ending around 6pm.  One diarrhea event at around 3 pm.  No fever, no appetite.  Feeling weak, tired.  Worry of dehydration.  Given small sips of water with diluted lemon/lime soda every 10 minutes ore so for two hours at least beginning at 7:30 pm.
PT WITH PARALYSIS IN THE LEFT UPPER AND LEFT LOWER EXTREMITY.  PT HAD MRI OF THE BRAIN PER  FACILITY REHAB WHICH WAS NEGATIVE FOR STROKE
Fever, fatigue, chills, injection site pain Narrative: Within  24 hours of the vaccine developed fever, chills, and fatigue. The patient also reported injection site pain.
Patient had not had previous COVID Vaccine immunizations, but was administered a bivalent booster instead of a monovalent dose. Patient was informed of the error, scheduled for dose 2 monovalent 3 weeks post vaccination.
SHORTNESS OF BREATH; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, expiry: 25-MAY-2021) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced shortness of breath. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shortness of breath on 13-MAR-2021. This report was non-serious.
2nd day started fever, reached 101.2.  Pulse increased to over 110 and BP up to 153/106, and I went into AFib.
Pt. presents to clinic with a rash on his trunk that started in AM of 2/26/13 Pt has an erythematous papular rash on the abdomen, back & proximal extremities. Rash is not urticarial in nature mother denies itchiness or fevers noted. Mother instructed to continue Amoxicillin mother instructed to observe for rash worsens or becomes urticarial in nature or has swelling. Pt to be re-evaluated.
Type I Diabetes  6/6/08 Reviewed outpatient clinic records & vax records.   FINAL DX: Type 1 diabetes w/peripheral cirvulatory disorder Records indicate that by 8/15 patient having difficulty sleeping, appetite decreased,irritability, polyuria & polydipsia x 2-3 weeks.  Referred to peds endocrinologist & started on insulin.  Returned to clinic 11/13 for recheck of acute suppurative OM, had completed antibiotics from 2 wks prior.   Developed hives 1/8/2008 s/p insulin injection.  6/10/08 Reviewed Endocrinology clinic medical records of 8/16/2007-5/9/2008. FINAL DX: New onset Type 1 diabetes Records reveal patient picky eater, father primary caregiver.  Family instructed on insulin & diet.  Patient received flu vaccine 10/18/07, no lot # available.  Continued w/fair diabetic control, felt would benefit from insulin pump & process started. Follow-up: Patient was diagnosed with Type 1 diabetes 1 month after receiving the Hep A vaccination. The high blood sugar symptoms began within about a week of receiving the vaccine. Type 1 diabetes will never go away. Although we recognize that Type 1 diabetes begins with an inherited susceptibility, we do still believe this vaccine had the environmental trigger that started the diabetes.
wed- felt ill, Thursday 10/01/2009 had temp 101 and r arm was swollen with redness to elbow. Friday was afebrile but arm painful and remained red and swollen.
16 hours post shot, developed severe myalgias all over body, fever of 101, pain in my spine, back neck, most of my muscles. Nausea. Lightheaded, dizzy. Left neck, chest and armpit lymphadenopathy.
Pt seen in ER 3/4/07 for eval of rash. Active, fussy, widely scattered, erythematous, papular areas noted on trunk, abd, arms and legs. They do not blouch. Not vesicular in their appearance.
Severe chills, headache, fatigue, lack of appetite. Chills lasted few hours. The rest lasted till 1.5 days.
On 1/22/21, I had dermal filler injected into my upper left eyelid. I received the Moderna COVID-19 Vaccine 3/25/21 @8:30am. Around 9:00pm on 3/26/21, I noticed that my upper left eyelid is swollen where the dermal filler was injected.
This spontaneous report as received from certified medical assistant refers to multiple patients of unknown age and gender. The patients' concurrent conditions, pertinent medical history and concomitant therapies were not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # N002202, expiration date 04-NOV-2019 and lot # M037248, expiration date 21-FEB-2019) (dose and route were not reported) for prophylaxis. The vaccine was exposed from 47 Fahrenheit (°F) degrees to 77 Fahrenheit (°F) degrees for 15 minutes. Also there was previous temperature excursion from 32 Fahrenheit (°F) degrees to 35 Fahrenheit (°F) degrees for 19 hours and 30 minutes and from 47 Fahrenheit (°F) degrees to 77 Fahrenheit (°F) degrees for 1 hour and 45 minutes. The call was made because there was a "data logger". No adverse effects were reported. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1709USA010094: US-009507513-1709USA010095: US-009507513-1709USA009372.
My body started to itch; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (My body started to itch) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medication history was provided.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (My body started to itch). At the time of the report, PRURITUS (My body started to itch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was unknown Treatment information was unknown
Normal soreness at injection site on day 1. Day 2 pain occurred  from upper arm to lower lateral arm area, It radiated around to scapula and up into the left side of the neck.  Two weeks post injection the pain is still prominent, and seems to at times rotate between the above sites, and sometimes all sites.  Pain on a 1-10 scale ranges from a 3 - 7 and muscles and skin are tender to the touch.  Acetaminophen 500mg q6hrs was of little help.  Methocarbamol 750mg q6 hrs was not useful. Ice seemed to help while applied but not much after.  Pain was that felt after a muscle spasm or charlie horse subsides - chronic ache and sometimes a throb.  Next will try gabapentin starting 7-13-21.
Patient describes feeling as if all of her nerves were on fire from 8:30 that morning after breakfast until around dinner time (4-4:30pm).
pt devel fever 102.4 had runny nose & cough on 26MAY95; pt ran fever until 30MAY95 seen by MD pt had ear infect & sore throat started on Amoxicillin;
Lymph node on my left side of neck near collarbone is sore and swollen.; Lymph node on my left side of neck near collarbone, is sore and swollen.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 20Apr2021 at 15:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included citalopram hydrobromide (CELEXA), estrogens conjugated (PREMARIN) and ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY) for adults, all taken for unspecified indications from unknown dates. The patient previously took erythromycin (MANUFACTURER UNKNOWN) and azithromycin (ZITHROMAX) and experienced drug allergy. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 13:00, the patient noticed that the lymph node on his left side of neck near the collarbone was sore and swollen. The patient did not seek any treatment, since research into possible side effects noted to swollen lymph nodes on the side where the vaccine was given. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event lymph node on left side of neck near collarbone was sore and swollen was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Currently on birth control, but experienced a period twice in each month for the last two months. Took birth control normally in the morning, with no changes. First period was about two weeks early, on the heavier side. The second was during the "sugar pill" week of my pack and a bit lighter.
patient received Moderna (lot # 037K20A.) for her first dose. Patient came to vaccination site for her second dose.  Patient received 2nd dose as Pfizer (Lot EL9262) instead of Moderna.  While reviewing her vaccination card during the 15 minute observation period, she realized that she received the wrong manufacturer/vaccine.  staff and supervisor were informed.  Patient was evaluated by NP on site and patient did not experience any adverse reaction to the Pfizer vaccine.
Patient c/o of being lightheaded after vaccination. States that she last ate around 9:00 am. RN noticed that she was a bit shaky too. Patient states that she was recently diagnosed DM II x 3 months ago. Vitals taken 122/80, HR 66, SPO2 95%, RR 18. Patient?s spouse whet out to get patient a Pepsi. She took a few drinks and started to feel better around 1400. RN provided education about diet, maintaining blood sugars, and keeping glucose monitor with her. Patient states that this is all new to her and she is still learning how to deal with diabetes. Patient states she if feeling much better at 1410 and left after verbalizing an understanding that she should follow up with her physician or go to ER if she should start to feel bad after leaving. She was accompanied by her significant other.
Information has been received from a RN concerning a 79 yr old white male photographer with a systolic murmur at the apex, a slow heart rate, no allergies and chronic lymphocytic leukaemia who on 15Oct96 was vaccinated IM in the left deltoid with a first 0.5ml dose of pneumococcal 23v polysaccharide vaccine. On 16Oct96 the pt developed swelling and pain at the injection site and surrounding tissue into the deltoid of the left arm. On 18Oct96 the pt was seen for an office visit where it was noted that the pt's pulse was 52 and the physician likes the slow heart rate. His spleen was noted to be decreased by 2cm which was reported as unchanged. On 23Oct96 the pt was seen at the physician's office who noted that the pt had had a hypersensitivity reaction to the vaccine and it was noted that he was now better and had recovered. An IgG test drawn on 18Oct96 was reported as increased. On 25Oct96 a repeat IgG test was noted as no change and then was noted as a lab error. An IgM test was reported as stable. It was also noted that there were no adverse events following prior vaccinations. No product quality complaint was involved. No further information is expected.
Child received 12 month immunizations and second flu shot on 1/16/2020. Child was at home with mother on 1/25/2020 when she noticed full body shaking and eyes deviated upward without blinking; this lasted 5-6 minutes. He had developed a fever about 2 hours prior to seizure. She took him to a local ED where he was diagnosed with simple febrile seizure. RSV/Flu PCR was negative. He did not have any viral symptoms, gastroenteritis symptoms, or AOM. He was discharged from the ED with seizure precautions. At followup on 1/29/2020, child had an erythematous macular non palpable, blanchable, non-itchy rash on his abdomen, legs, neck, chest, back, and face. No URI sx or other infectious sx at this time. No concern for contact dermatitis or eczema.
Pt rec'd immunizations 8/3/11. Mom called 8/4/11 - states very dizzy & arms very sore.
COVID vaccine breakthrough case. Pfizer EW0202 on 6/21/21 and 7/12/21, boosted on 11/21/21 FJ8757.
pt recvd vax; right after vax, pt exp soreness at deltoid muscle; also exp shoulder tightness;
Psoriasis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old male patient received BNT162b2 (BNT162B2), on 07Jan2022 at 12:00 as dose 3 (booster), single (Lot number: FH8030) at the age of 30 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Epilepsy" (unspecified if ongoing); "Leukemia" (unspecified if ongoing), notes: in remission for 25 years; "Covid" (unspecified if ongoing). Concomitant medication(s) included: ESCITALOPRAM; LAMICTAL. Past drug history included: Vencomyicin, reaction(s): "Known allergies: Vencomyicin". Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: EL9261; Anatomical Location: Left Arm; Time of administration: 12:00 PM), administration date: 20Jan2021, when the patient was 29-year-old, for Covid-19 Immunization; BNT162b2 (DOSE 2, SINGLE; Lot number: EL2966; Anatomical Location: Left Arm; Time of administration: 12:00 PM), administration date: 10Feb2021, when the patient was 29-year-old, for Covid-19 Immunization. The following information was reported: PSORIASIS (non-serious) with onset 20May2022 at 12:00, outcome "not recovered". The event "psoriasis" required physician office visit. Therapeutic measures were taken as a result of psoriasis.  Additional Information: It was reported that patient did not receive any other vaccine in four weeks and was not tested for COVID post vaccination.
Bell's Palsy; This is a spontaneous report from a contactable consumer or other non HCP. This consumer reported same events for three patients (nurses). This is 2nd of 3 reports. A patient of an unknown age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, also reported as COMIRNATY), via an unspecified route of administration on unknown date in Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were unknown. Healthcare worker reported that 3 nurses who work in her facility received Pfizer's COVID vaccine last week (Dec2020) came in with Bell's Palsy in Dec2020. Event took place after use of product. The outcome of event was unknown.   No follow-up attempts are possible. Information about batch/Lot number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020519105 same reporter, same drug, same event, different patients;US-PFIZER INC-2020519119 same reporter, same drug, same event, different patients
Information has been received from a certified medical assistant concerning a patient of unknown age and gender. No medical history or concurrent conditions were reported. On 03-MAR-2015 the patient was vaccinated with (Oka/Merck) VARIVAX, subcutaneously (dose, strength, frequency and lot number were not provided) which was improperly stored. Co-suspect or concomitant therapies were not provided. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Severe chills, body aches,  fever, headache, nausea.  Started at round 2:30am (shot received 14 hours prior). The chills woke me up. I took Tylenol and slept on and off. I got out of bed around 10AM the next day (took a sick day) and ate a scrambled egg and some toast. I drank Gatorade and ginger ale. The body aches, fever and headache continued. The nausea was on and off. I slept for a few hours and when I woke up around 4:30p, I felt a bit better. I ate some vegetable soup for dinner and gradually felt better. Around 10:30pm I got extremely nauseous and threw up several times. I went to bed and felt mostly normal the following day.   On March  28, I noticed a large red mark on my arm several inches below the shot site. The patch looks like a reddish rash, it feels warm and itches intermittently. The rash is still visible today, March 30.
Within 1-2 hours after the vaccine was given on the left thigh, the patient developed a large red rash spreading down her left leg and up her hip as well to her waist. Mother states that she was very fussy and seemed to be uncomfortable. The rash was bright red, raised and warm to the touch. It took several days for the rash to finally go away with the help of benadryl.
65yr old patient presented on 1/4/22 for well visit.  Patient was ordered Pneumococcal polysaccharide vaccine 23-valent greater than or equal to 2yo SQ/IM (PNEUMOVAX-23) to be administered during visit.  RN administered Pneumococcal Polysaccharide 23-Valent (Pneumovax-23) LOT # U010533 IM in patient's left deltoid.  On 1/5, patient contacted office to report should pain and swelling near injection site.  Patient indicated limited range of motion.  Patient endorsed taking acetaminophen without improvement.  Patient felt may have "bursitis" and needs steroid injection.  Patient scheduled ortho sports medicine appointment (1/11/22) however, later canceled as symptoms improved.
Started with a shoulder ache that grew into my arm was on fire.  By 5 p.m. I had a 4 inch round red spot that had a dome of probably 1/4 inch. It was red hot.  It spread to my left-side neck and was very painful to raise arm & was causing dizziness around 7 p.m.  By 9 p.m. my right ankle on the back of my calf started swelling.  Swelled a good inch.  I iced up the arm and ankle and left my ankle raised a few hours before it started feeling better.  This morning everything that hurt yesterday is much better but feels like I am bruised but nothing showing.  I started the morning very weak. Better by noon but still wobbly.